Sickle Cell Disease Vepoloxamer (MST-188) August 4, 2016[email protected] Vepoloxamer (MST-188) is an investigational drug designed to minimize the deleterious effects of a sickle cell crisis that may bring an epic change to the treatment of sickle cell disease.
